1
|
Gattu R, Ramesh SS, Nadigar S, D CG, Ramesh S. Conjugation as a Tool in Therapeutics: Role of Amino Acids/Peptides-Bioactive (Including Heterocycles) Hybrid Molecules in Treating Infectious Diseases. Antibiotics (Basel) 2023; 12:antibiotics12030532. [PMID: 36978399 PMCID: PMC10044335 DOI: 10.3390/antibiotics12030532] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/09/2023] [Revised: 02/28/2023] [Accepted: 03/03/2023] [Indexed: 03/30/2023] Open
Abstract
Peptide-based drugs are gaining significant momentum in the modern drug discovery, which is witnessed by the approval of new drugs by the FDA in recent years. On the other hand, small molecules-based drugs are an integral part of drug development since the past several decades. Peptide-containing drugs are placed between small molecules and the biologics. Both the peptides as well as the small molecules (mainly heterocycles) pose several drawbacks as therapeutics despite their success in curing many diseases. This gap may be bridged by utilising the so called 'conjugation chemistry', in which both the partners are linked to one another through a stable chemical bond, and the resulting conjugates are found to possess attracting benefits, thus eliminating the stigma associated with the individual partners. Over the past decades, the field of molecular hybridisation has emerged to afford us new and efficient molecular architectures that have shown high promise in medicinal chemistry. Taking advantage of this and also considering our experience in this field, we present herein a review concerning the molecules obtained by the conjugation of peptides (amino acids) to small molecules (heterocycles as well as bioactive compounds). More than 125 examples of the conjugates citing nearly 100 references published during the period 2000 to 2022 having therapeutic applications in curing infectious diseases have been covered.
Collapse
Affiliation(s)
- Rohith Gattu
- Postgraduate Department of Chemistry, JSS College of Arts, Commerce and Science, Ooty Road, Mysuru 570025, Karnataka, India
| | - Sanjay S Ramesh
- Postgraduate Department of Chemistry, JSS College of Arts, Commerce and Science, Ooty Road, Mysuru 570025, Karnataka, India
| | - Siddaram Nadigar
- Postgraduate Department of Chemistry, JSS College of Arts, Commerce and Science, Ooty Road, Mysuru 570025, Karnataka, India
| | - Channe Gowda D
- Department of Studies in Chemistry, Manasagangotri, University of Mysore, Mysuru 570005, Karnataka, India
| | - Suhas Ramesh
- Postgraduate Department of Chemistry, JSS College of Arts, Commerce and Science, Ooty Road, Mysuru 570025, Karnataka, India
| |
Collapse
|
2
|
Anti-diabetic potential, crystal structure, molecular docking, DFT, and optical-electrochemical studies of new dimethyl and diethyl carbamoyl-N, N′-disubstituted based thioureas. J Mol Struct 2022. [DOI: 10.1016/j.molstruc.2021.132207] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
|
3
|
Kafarski P. Phosphonopeptides containing free phosphonic groups: recent advances. RSC Adv 2020; 10:25898-25910. [PMID: 35518575 PMCID: PMC9055344 DOI: 10.1039/d0ra04655h] [Citation(s) in RCA: 12] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/26/2020] [Accepted: 07/02/2020] [Indexed: 11/21/2022] Open
Abstract
Phosphonopeptides are mimetics of peptides in which phosphonic acid or related (phosphinic, phosphonous etc.) group replaces either carboxylic acid group present at C-terminus, is located in the peptidyl side chain, or phosphonamidate or phosphinic acid mimics peptide bond. Acting as inhibitors of key enzymes related to variable pathological states they display interesting and useful physiologic activities with potential applications in medicine and agriculture. Since the synthesis and biological properties of peptides containing C-terminal diaryl phosphonates and those with phosphonic fragment replacing peptide bond were comprehensively reviewed, this review concentrate on peptides holding free, unsubstituted phosphonic acid moiety. There are two groups of such mimetics: (i) peptides in which aminophosphonic acid is located at C-terminus of the peptide chain with most of them (including antibiotics isolated from bacteria and fungi) exhibiting antimicrobial activity; (ii) non-hydrolysable analogues of phosphonoamino acids, which are useful tools to study physiologic effects of phosphorylations.
Collapse
Affiliation(s)
- Paweł Kafarski
- Department of Bioorganic Chemistry, Wrocław University of Science and Technology Wybrzeże Wyspiańskiego 27 50-305 Wrocław Poland
| |
Collapse
|
4
|
Thomas SJ, Balónová B, Cinatl J, Wass MN, Serpell CJ, Blight BA, Michaelis M. Thiourea and Guanidine Compounds and Their Iridium Complexes in Drug‐Resistant Cancer Cell Lines: Structure‐Activity Relationships and Direct Luminescent Imaging. ChemMedChem 2020; 15:349-353. [DOI: 10.1002/cmdc.201900591] [Citation(s) in RCA: 14] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/21/2019] [Revised: 11/30/2019] [Indexed: 01/15/2023]
Affiliation(s)
- Samuel J. Thomas
- School of BiosciencesUniversity of Kent Stacey Building, Canterbury Kent CT2, 7NJ UK
| | - Barbora Balónová
- Department of ChemistryUniversity of New Brunswick Fredericton New Brunswick E3B 5A3 Canada
| | - Jindrich Cinatl
- Institute of Medical VirologyGoethe University Frankfurt Paul-Ehrlich-Strasse 40 60596 Frankfurt am Main Germany
| | - Mark N. Wass
- School of BiosciencesUniversity of Kent Stacey Building, Canterbury Kent CT2, 7NJ UK
| | - Christopher J. Serpell
- School of Physical SciencesUniversity of Kent Ingram Building Canterbury Kent CT2 7NH UK
| | - Barry A. Blight
- Department of ChemistryUniversity of New Brunswick Fredericton New Brunswick E3B 5A3 Canada
| | - Martin Michaelis
- School of BiosciencesUniversity of Kent Stacey Building, Canterbury Kent CT2, 7NJ UK
| |
Collapse
|
5
|
Shao D, Zhang GN, Niu W, Li Z, Zhu M, Wang J, Li D, Wang Y. Design, Synthesis, and Cytotoxic Activity of 3-Aryl-N-hydroxy-2-(sulfonamido)propanamides in HepG2, HT-1080, KB, and MCF-7 Cells. Chem Biodivers 2019; 16:e1800646. [PMID: 30706997 DOI: 10.1002/cbdv.201800646] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/04/2018] [Accepted: 02/01/2019] [Indexed: 01/12/2023]
Abstract
A new series of (sulfonamido)propanamides (6a1-6a13, 6b1-6b15, 7c1-7c5, 6d1-6d5, 6e1-6e6) was designed and synthesized. All the synthesized compounds were characterized by NMR and mass spectrometry. The target compounds were evaluated for their in vitro cytotoxic activity against hepatocellular carcinoma (HepG2), fibrosarcoma (HT-1080), mouth epidermal carcinoma (KB), and breast adenocarcinoma (MCF-7) cell lines with the sulforhodamine B (SRB) assay, with gemcitabine and mitomycin C as positive controls. Most of these compounds exhibit a more potent cytotoxic effect than the positive control group on various cancer cell lines and the most potent compound, 6a7, shows the IC50 values of 29.78±0.516 μm, 30.70±0.61 μm, and 64.89±3.09 μm in HepG2, HT-1080, KB, and MCF-7 cell lines, respectively. Thus, these compounds with potent cytotoxic activity have potential for development as new chemotherapy agents.
Collapse
Affiliation(s)
- Duanyang Shao
- School of Pharmacy, Jinzhou Medical University, Jinzhou, 121001, P. R. China
| | - Guo-Ning Zhang
- Institute of Medicinal Biotechnology, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, 100050, P. R. China
| | - Weixiao Niu
- Institute of Medicinal Biotechnology, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, 100050, P. R. China
| | - Ziqiang Li
- Institute of Medicinal Biotechnology, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, 100050, P. R. China
| | - Mei Zhu
- Institute of Medicinal Biotechnology, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, 100050, P. R. China
| | - Juxian Wang
- Institute of Medicinal Biotechnology, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, 100050, P. R. China
| | - Donghui Li
- School of Pharmacy, Jinzhou Medical University, Jinzhou, 121001, P. R. China
| | - Yucheng Wang
- Institute of Medicinal Biotechnology, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, 100050, P. R. China
| |
Collapse
|